130 related articles for article (PubMed ID: 31954097)
1. Preclinical safety and antitumor activity of the arginine-degrading therapeutic enzyme pegzilarginase, a PEGylated, cobalt-substituted recombinant human arginase 1.
Agnello G; Alters SE; Rowlinson SW
Transl Res; 2020 Mar; 217():11-22. PubMed ID: 31954097
[TBL] [Abstract][Full Text] [Related]
2. Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth.
Badeaux MD; Rolig AS; Agnello G; Enzler D; Kasiewicz MJ; Priddy L; Wiggins JF; Muir A; Sullivan MR; Van Cleef J; Daige C; Vander Heiden MG; Rajamanickam V; Wooldridge JE; Redmond WL; Rowlinson SW
Cancer Immunol Res; 2021 Apr; 9(4):415-429. PubMed ID: 33500272
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer.
Xu S; Lam SK; Cheng PN; Ho JC
Cancer Sci; 2018 Nov; 109(11):3471-3482. PubMed ID: 30155941
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes.
Alexandrou C; Al-Aqbi SS; Higgins JA; Boyle W; Karmokar A; Andreadi C; Luo JL; Moore DA; Viskaduraki M; Blades M; Murray GI; Howells LM; Thomas A; Brown K; Cheng PN; Rufini A
Sci Rep; 2018 Aug; 8(1):12096. PubMed ID: 30108309
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
[TBL] [Abstract][Full Text] [Related]
6. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
[TBL] [Abstract][Full Text] [Related]
7. Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy.
Carpentier J; Pavlyk I; Mukherjee U; Hall PE; Szlosarek PW
Lung Cancer (Auckl); 2022; 13():53-66. PubMed ID: 36091646
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.
Lam TL; Wong GK; Chong HC; Cheng PN; Choi SC; Chow TL; Kwok SY; Poon RT; Wheatley DN; Lo WH; Leung YC
Cancer Lett; 2009 May; 277(1):91-100. PubMed ID: 19138817
[TBL] [Abstract][Full Text] [Related]
9. The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100.
De Santo C; Booth S; Vardon A; Cousins A; Tubb V; Perry T; Noyvert B; Beggs A; Ng M; Halsey C; Kearns P; Cheng P; Mussai F
Int J Cancer; 2018 Apr; 142(7):1490-1502. PubMed ID: 29168171
[TBL] [Abstract][Full Text] [Related]
10. Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency.
Diaz GA; Schulze A; McNutt MC; Leão-Teles E; Merritt JL; Enns GM; Batzios S; Bannick A; Zori RT; Sloan LS; Potts SL; Bubb G; Quinn AG
J Inherit Metab Dis; 2021 Jul; 44(4):847-856. PubMed ID: 33325055
[TBL] [Abstract][Full Text] [Related]
11. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.
Khoury O; Ghazale N; Stone E; El-Sibai M; Frankel AE; Abi-Habib RJ
J Neurooncol; 2015 Mar; 122(1):75-85. PubMed ID: 25567351
[TBL] [Abstract][Full Text] [Related]
12. Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells.
Yeh TH; Chen YR; Chen SY; Shen WC; Ann DK; Zaro JL; Shen LJ
Mol Pharm; 2016 Jan; 13(1):262-71. PubMed ID: 26642391
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells.
Agrawal V; Woo JH; Mauldin JP; Jo C; Stone EM; Georgiou G; Frankel AE
Anticancer Drugs; 2012 Jan; 23(1):51-64. PubMed ID: 21955999
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis.
Lam TL; Wong GK; Chow HY; Chong HC; Chow TL; Kwok SY; Cheng PN; Wheatley DN; Lo WH; Leung YC
Pigment Cell Melanoma Res; 2011 Apr; 24(2):366-76. PubMed ID: 21029397
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trial.
Russo RS; Gasperini S; Bubb G; Neuman L; Sloan LS; Diaz GA; Enns GM;
EClinicalMedicine; 2024 Feb; 68():102405. PubMed ID: 38292042
[TBL] [Abstract][Full Text] [Related]
16. Pegylated arginase I: a potential therapeutic approach in T-ALL.
Hernandez CP; Morrow K; Lopez-Barcons LA; Zabaleta J; Sierra R; Velasco C; Cole J; Rodriguez PC
Blood; 2010 Jun; 115(25):5214-21. PubMed ID: 20407034
[TBL] [Abstract][Full Text] [Related]
17. Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment.
Yu KM; Pang TP; Cutler M; Tian M; Huang L; Lau JY; Chung SF; Lo TW; Leung TY
Life Sci; 2021 Jan; 264():118674. PubMed ID: 33129876
[TBL] [Abstract][Full Text] [Related]
18. Effects of the combined arginase and canavanine treatment on leukemic cells in vitro and in vivo.
Vovk OI; Chen OI; Igumentseva NI; Senchuk OY; Barska ML; Sybirna NO; Stasyk OV
Ukr Biochem J; 2016; 88(2):45-55. PubMed ID: 29227602
[TBL] [Abstract][Full Text] [Related]
19. Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells.
Qiu F; Chen YR; Liu X; Chu CY; Shen LJ; Xu J; Gaur S; Forman HJ; Zhang H; Zheng S; Yen Y; Huang J; Kung HJ; Ann DK
Sci Signal; 2014 Apr; 7(319):ra31. PubMed ID: 24692592
[TBL] [Abstract][Full Text] [Related]
20. Blocking autophagy enhanced leukemia cell death induced by recombinant human arginase.
Li Y; Zeng X; Wang S; Fan J; Wang Z; Song P; Mei X; Ju D
Tumour Biol; 2016 May; 37(5):6627-35. PubMed ID: 26643895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
